DE60228968D1 - Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon - Google Patents

Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon

Info

Publication number
DE60228968D1
DE60228968D1 DE60228968T DE60228968T DE60228968D1 DE 60228968 D1 DE60228968 D1 DE 60228968D1 DE 60228968 T DE60228968 T DE 60228968T DE 60228968 T DE60228968 T DE 60228968T DE 60228968 D1 DE60228968 D1 DE 60228968D1
Authority
DE
Germany
Prior art keywords
deramciclan
damages
treating
cognitive functions
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60228968T
Other languages
English (en)
Inventor
Istvan Gacsalyi
Gyoergy Levay
Gyoenoes Ildiko Nagyne
Laszlo Gabor Harsing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Application granted granted Critical
Publication of DE60228968D1 publication Critical patent/DE60228968D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE60228968T 2001-07-18 2002-07-18 Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon Expired - Fee Related DE60228968D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0103017A HUP0103017A3 (en) 2001-07-18 2001-07-18 Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
PCT/HU2002/000069 WO2003007926A2 (en) 2001-07-18 2002-07-18 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions

Publications (1)

Publication Number Publication Date
DE60228968D1 true DE60228968D1 (de) 2008-10-30

Family

ID=90001562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228968T Expired - Fee Related DE60228968D1 (de) 2001-07-18 2002-07-18 Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon

Country Status (18)

Country Link
US (1) US20040171696A1 (de)
EP (1) EP1408940B1 (de)
JP (1) JP2004537548A (de)
KR (1) KR20040017326A (de)
CN (1) CN1545410A (de)
AT (1) ATE408403T1 (de)
CA (1) CA2453834A1 (de)
CZ (1) CZ200460A3 (de)
DE (1) DE60228968D1 (de)
EA (1) EA006897B1 (de)
HU (1) HUP0103017A3 (de)
IL (1) IL159841A0 (de)
PL (1) PL365258A1 (de)
RS (1) RS4904A (de)
SK (1) SK312004A3 (de)
UA (1) UA78714C2 (de)
WO (1) WO2003007926A2 (de)
ZA (1) ZA200400481B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
EP1500391A1 (de) * 2003-07-24 2005-01-26 Neuro3D Medizinische Verwendung von Bicycloheptan-Derivaten
US20080021016A1 (en) * 2004-03-12 2008-01-24 Levay Gyoergy Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions
AU2004317128A1 (en) * 2004-03-12 2005-09-22 Egis Gyogyszergyar Nyrt Combination of deramciclane and opoids as analgesics
KR101642113B1 (ko) 2014-10-08 2016-07-25 원광대학교산학협력단 퇴행성 뇌질환을 예방, 개선 또는 치료하는 유황의 법제 방법 및 상기 방법으로 법제된 유황
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement

Also Published As

Publication number Publication date
EA006897B1 (ru) 2006-04-28
ZA200400481B (en) 2005-01-24
EP1408940A2 (de) 2004-04-21
HUP0103017A2 (hu) 2003-07-28
IL159841A0 (en) 2004-06-20
UA78714C2 (en) 2007-04-25
CA2453834A1 (en) 2003-01-30
WO2003007926A3 (en) 2003-09-18
KR20040017326A (ko) 2004-02-26
PL365258A1 (en) 2004-12-27
EP1408940B1 (de) 2008-09-17
CZ200460A3 (cs) 2004-05-12
RS4904A (en) 2006-10-27
WO2003007926A2 (en) 2003-01-30
ATE408403T1 (de) 2008-10-15
HUP0103017D0 (en) 2001-10-28
US20040171696A1 (en) 2004-09-02
JP2004537548A (ja) 2004-12-16
CN1545410A (zh) 2004-11-10
SK312004A3 (en) 2004-06-08
HUP0103017A3 (en) 2004-05-28
EA200400192A1 (ru) 2004-06-24

Similar Documents

Publication Publication Date Title
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
SE0403006D0 (sv) New compounds
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
BR0200782A (pt) Compostos para o tratamento da isquemia
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
UY27368A1 (es) Nuevos compuestos
JO2282B1 (en) Oxazole derivatives
EP1562897A4 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
GB0225475D0 (en) Therapeutic agents
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
BRPI0610644B8 (pt) composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
ATE384058T1 (de) Thiazolderivate
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MXPA05010020A (es) Derivados de oxamida.
DE60228968D1 (de) Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon
BR0305708A (pt) Derivados de benzimidazol para o tratamento de disfunção sexual
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee